Standout Papers

Safety and Efficacy of Liraglutide, 3.0 mg, Once Daily vs Placebo in Patients With Poor Weight Loss Following Metabolic Surgery 2023 2026 202471
  1. Safety and Efficacy of Liraglutide, 3.0 mg, Once Daily vs Placebo in Patients With Poor Weight Loss Following Metabolic Surgery (2023)
    Jessica Mok, Adrian Brown et al. JAMA Surgery

Immediate Impact

67 standout
Sub-graph 1 of 23

Citing Papers

Obesity in adults
2024 Standout
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
2024 Standout
3 intermediate papers

Works of Cormac Magee being referenced

Safety and Efficacy of Liraglutide, 3.0 mg, Once Daily vs Placebo in Patients With Poor Weight Loss Following Metabolic Surgery
2023 Standout
Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: one year results from the first international, open-label, prospective, multicentre study
2019

Author Peers

Author Last Decade Papers Cites
Cormac Magee 253 126 49 99 22 398
J Fakhry 179 50 66 50 20 456
Yuan‐Chen Wang 166 71 112 28 27 449
E. Øster-Jørgensen 149 90 192 117 31 389
H. A. J. Gielkens 181 43 128 103 28 357
Michel De Roo 77 67 92 68 20 398
Sonlee D. West 162 81 22 41 29 386
Gönül Koç 91 30 25 22 28 336
R M R Taylor 166 103 37 28 20 373
B Whitney 146 152 89 74 16 398
Martin E. Eisner 188 49 122 68 15 378

All Works

Loading papers...

Rankless by CCL
2026